Brain Stem Gliomas Completed Phase 1 Trials for Erlotinib (DB00530)

Also known as: Brain Stem Glioma / Brainstem Glioma / Glioma of brainstem

IndicationStatusPhase
DBCOND0087392 (Brain Stem Gliomas)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00418327Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem GliomaTreatment